Fig. 12From: Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine modelSchematic representation of the dose schedule applied to evaluate the antitumor response in the in-vivo studyBack to article page